Indian Immunologicals Limited (IIL) partnered with the Central Institute of Freshwater Aquaculture, Bhubaneswar, an Indian Council of Agricultural Research (ICAR) Institute, for the commercial development of a vaccine against hemorrhagic septicemia in freshwater fish.
TheIIL ventured into the aquaculture business in October 2022 by launching products for the aquaculture health market dealing with pond management and fish or shrimp gut management and subsequently announced commercial development of fish vaccines with ICAR-CIFE.
“IIL is the first in India to get fish vaccines. We are aware of the challenges associated with being the first, having been in similar situations for many other livestock vaccines. We are working at multiple fronts in defining pathways for commercial development of fish vaccines in India,” said K Anand Kumar, managing director of IIL.